Vimarsana
Biggest News Aggregation in the World

Page 8 - Recommendation Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recommendation Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recommendation Statement Today - Breaking & Trending Today

Wyndham Board Urges Shareholders to Reject Inadequate and Highly Conditional Choice Exchange Offer - Vimarsana News

Wyndham Board Urges Shareholders to Reject Inadequate and Highly Conditional Choice Exchange Offer

Wyndham Hotels & Resorts (NYSE: WH) (“Wyndham” or the “Company”), today announced that its Board of Directors, following a comprehensive review with its outside financial and legal advisors, has unanimously determined the unsolicited exchange offer (the “Offer”) from Choice Hotels International, Inc. (NYSE: CHH) (“Choice”) to acquire all outstanding shares of Wyndham is NOT in the best interests of Wyndham and its shareholders. The Wyndham Board of Directors unanimously recommends that shareholders NOT tender any of their shares into the Offer.

Wyndham Board Urges Shareholders to Reject Inadequate and Highly Conditional Choice Exchange Offer - Vimarsana News

Wyndham Board Urges Shareholders to Reject Inadequate and Highly Conditional Choice Exchange Offer

Board Unanimously Recommends Wyndham Shareholders NOT Tender Shares Choice Ignores Significant Regulatory and Business Risks and Misleads Wyndham Shareholders and Other Stakeholders...

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer - Vimarsana News

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

Phase 3 SPLASH study of 177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival BEDFORD, Mass., and INDIANAPOLIS, Dec. 18, 2023 -- December...

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023 - Vimarsana News

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023

INDIANAPOLIS, Dec. 18, 2023 /PRNewswire/ -- Eli Lilly and Company today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares of common...

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in ... - Vimarsana News

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in ...

Phase 3 SPLASH study of177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival (rPFS)